Srihari Gopal Selected Research

Injections

1/2022	A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia.
1/2021	Impact on carer burden when stable patients with schizophrenia transitioned from 1-monthly to 3-monthly paliperidone palmitate.
1/2021	Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview.
1/2020	Stable patients with schizophrenia switched to paliperidone palmitate 3-monthly formulation in a naturalistic setting: impact of patient age and disease duration on outcomes.
1/2020	Improvement of Negative Symptoms in Schizophrenia with Paliperidone Palmitate 1-Month and 3-Month Long-Acting Injectables: Results from a Phase 3 Non-Inferiority Study.
1/2020	Patients' Preference for Long-Acting Injectable versus Oral Antipsychotics in Schizophrenia: Results from the Patient-Reported Medication Preference Questionnaire.
11/2019	Pharmacokinetic-Pharmacodynamic Characterization of Relapse Risk for Paliperidone Palmitate 1-Month and 3-Month Formulations.
3/2019	Low Incidence of Neuroleptic Malignant Syndrome Associated With Paliperidone Palmitate Long-Acting Injectable: A Database Report and Case Study.
1/2019	Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia.
10/2018	An assessment of injection site reaction and injection site pain of 1-month and 3-month long-acting injectable formulations of paliperidone palmitate.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Srihari Gopal Research Topics

Disease

60	Schizophrenia (Dementia Praecox) 01/2022 - 08/2009
7	Psychotic Disorders (Schizoaffective Disorder) 01/2018 - 08/2005
5	Tremor (Tremors) 01/2019 - 01/2011
4	Dyskinesias (Dyskinesia) 01/2019 - 01/2011
4	Psychomotor Agitation (Akathisia) 01/2019 - 01/2011
4	Pain (Aches) 10/2018 - 06/2010
3	Parkinsonian Disorders (Parkinsonism) 01/2019 - 09/2010
3	Hyperprolactinemia 09/2017 - 10/2012
3	Headache (Headaches) 08/2015 - 05/2011
2	Sleepiness 11/2016 - 02/2015
2	Weight Gain 11/2016 - 02/2015
2	Mania (Manias) 01/2014 - 08/2005
1	Neurodevelopmental Disorders 01/2022
1	Neuroleptic Malignant Syndrome 03/2019
1	Injection Site Reaction 10/2018
1	Orthostatic Hypotension (Postural Hypotension) 11/2016
1	Nasopharyngitis 08/2015
1	Hyperkinesis 02/2015
1	Dystonia (Limb Dystonia) 02/2015
1	Mental Disorders (Mental Disorder) 01/2014
1	Sleep Initiation and Maintenance Disorders (Insomnia) 05/2011
1	Delirium 02/2011
1	Tardive Dyskinesia 01/2011
1	Myalgia 06/2010
1	Dizziness (Lightheadedness) 06/2010
1	Bipolar Disorder (Manic Depressive Psychosis) 08/2005

Drug/Important Bio-Agent (IBA)

59	Paliperidone Palmitate FDA Link 01/2022 - 08/2009
25	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 02/2010
8	Risperidone (Risperdal Consta)FDA LinkGeneric 08/2018 - 08/2005
5	ProlactinIBA 01/2018 - 10/2012
2	Aripiprazole (Abilify)FDA Link 01/2018 - 02/2015
2	TabletsIBA 11/2016 - 08/2014
2	Cholinergic Antagonists (Anticholinergics)IBA 11/2016 - 01/2011
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2022
1	Sp4 Transcription FactorIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2021
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2018
1	Dopamine (Intropin)FDA LinkGeneric 01/2018
1	CholesterolIBA 11/2016
1	Glucose (Dextrose)FDA LinkGeneric 11/2016
1	HDL LipoproteinsIBA 11/2016
1	Olanzapine (Zyprexa)FDA Link 01/2014
1	bromperidol (Impromen)IBA 01/2011
1	fluphenazine depot (modecate)FDA LinkGeneric 01/2011
1	Haloperidol (Haldol)FDA LinkGeneric 01/2011
1	bromperidol decanoateIBA 01/2011
1	haloperidol decanoate FDA LinkGeneric 01/2011

Therapy/Procedure

31	Injections 01/2022 - 08/2009
9	Secondary Prevention 01/2020 - 06/2010
1	Aftercare (After-Treatment) 01/2018
1	Therapeutics 01/2016
1	Intramuscular Injections 09/2014